SOFDRA

Growth

sofpironium bromide

Botanix Pharmaceuticals
NDATOPICALGEL, METERED
Approved
Jun 2024
Lifecycle
Growth
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
May 22, 2040
173 months away
Patent Expiry
May 22, 2040
Exclusivity Expiry
Jun 20, 2029

Patent Records (5)

Patent #ExpiryTypeUse Code
8628759
Nov 13, 2026
U-2398
8147809
Mar 26, 2027
SubstanceProduct
—
10383846
Mar 14, 2034
U-2398
9220707
Mar 14, 2034
U-2398
9492429
Mar 14, 2034
Product
U-2398
Company
Botanix Pharmaceuticals
Botanix Pharmaceuticals
Australia - West Perth
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers